Actinium Pharmaceuticals
ATNM
#10524
Rank
โ‚น3.24 B
Marketcap
โ‚น103.40
Share price
2.86%
Change (1 day)
-30.56%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2026 (TTM): -โ‚น2.28 Billion

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are โ‚น0.09 Million. In 2025 the company made an earning of -โ‚น3.48 Billion, an increase over its 2024 earnings that were of -โ‚น4.04 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น2.28 Billion-34.4%
2025 -โ‚น3.48 Billion-13.95%
2024 -โ‚น4.04 Billion-18.87%
2023 -โ‚น4.98 Billion52.24%
2022 -โ‚น3.27 Billion36.61%
2021 -โ‚น2.4 Billion11.48%
2020 -โ‚น2.15 Billion1.46%
2019 -โ‚น2.12 Billion-7.37%
2018 -โ‚น2.29 Billion-11.46%
2017 -โ‚น2.58 Billion10.67%
2016 -โ‚น2.33 Billion15.7%
2015 -โ‚น2.02 Billion-14.86%
2014 -โ‚น2.37 Billion129.19%
2013 -โ‚น1.04 Billion-8.55%
2012 -โ‚น1.13 Billion
2010 โ‚น0.79 M-152.15%
2009 -โ‚น1.53 Million-39.8%
2008 -โ‚น2.53 Million120.29%
2007 -โ‚น1.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-โ‚น3.57 Billion 45.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น18.28 M-100.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น36.91 B-1,611.42%๐Ÿ‡บ๐Ÿ‡ธ USA